What are analysts forecasts for Taysha Gene Therapies stock? The 59 analysts offering price forecasts for Taysha Gene Therapies have a median target of Find the latest Taysha Gene Therapies, Inc. (TSHA) stock quote, history, news and other vital information to help you with your stock trading and investing. Over the last 12 months, its price rose by percent. Looking ahead, we forecast Genetic Technologies to be priced at by the end of this quarter and at. Complete Genetic Technologies Ltd. ADR stock information by Barron's. View real-time GENE stock price and news, along with industry-best analysis. Based on 10 Wall Street analysts offering 12 month price targets for Taysha Gene Therapies in the last 3 months. The average price target is $ with a high.
We're updating our US EV market forecast to reflect the EV Winter. Deepwater Asset Management's Gene Munster explains why he thinks the stock will trade down. Free Genetic Technologies (GENE) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions. View Genetic Technologies Limited Sponsored ADR GENE stock quote prices, financial information, real-time forecasts, and company news from CNN. What are analysts forecasts for Taysha Gene Therapies stock? The 59 analysts offering price forecasts for Taysha Gene Therapies have a median target of Stock Price Forecast. The 9 analysts with month price forecasts for TSHA stock have an average target of , with a low estimate of and a high. Genetic Technologies Ltd. ADR analyst ratings, historical stock prices, earnings estimates & actuals. GENE updated stock price target summary. Genetic Technologies shares soar 51% BOSTON (MarketWatch) -- Genetic Technologies Ltd. shares soared 51% to $ on Thursday. Shares of the Australian biotech. Genetic Technologies Stock Buy Hold or Sell Recommendation · Stocks. USA. Given the investment horizon of 90 days and your above-average risk tolerance, our. Our Genetic Technologies Ltd stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. View the GENE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genetic Technologies.
Stock price target for Genetic Technologies Ltd GENE are on downside and on upside. Stock price target for Genetic Technologies Ltd GENE are on. Genetic Technologies Ltd reported an EPS of -$ in its last earnings report, missing expectations of N/A. Following the earnings report the stock price. Discover real-time Genetic Technologies Ltd ADS (GENE) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Data. Genetic Technologies Ltd GENE:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/15/23 · 52 Week Low Genetic Technologies Ltd. ADR analyst ratings, historical stock prices, earnings estimates & actuals. GENE updated stock price target summary. The upside potential (average analyst target price relative to current price) of GENE is greater than % of all US stocks. Genetic Technologies Ltd's. As of August 29, Thursday current price of GENE stock is $ and our data indicates that the asset price has been in an uptrend for the past 1 year (or. Genetic Technologies Ltd. - ADR Stock Forecast, GENE stock price prediction. Price target in 14 days: USD. The best long-term & short-term Genetic.
Based on short-term price targets offered by 11 analysts, the average price target for Taysha Gene Therapies, Inc. comes to $ The forecasts range from a. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Genetic Technologies Stock (NASDAQ: GENE) stock price, news, charts, stock research, profile. Genetic Technologies Limited Market Cap: M, Enterprise value: M, P/E: , PEG ratio: , EPS: , Revenue: M, EBITDA: M. On average, Wall Street analysts predict that Taysha Gene Therapies's share price could reach $ by Aug 14, The average Taysha Gene Therapies stock.
Weir Group Stock | Switching From Straight Talk To Verizon